Mouth care for the dying.

Abstract

centrations ofmorphine. Clin Pharmacokinetics 1982;7:266-279 23. Sawe J, Dahlstrom B, Paazlow L, Rane A: Morphine kinetics in cancer patients. Clin Pharmacol Ther 1981; 30: 629-635 24. SAwe J, Hansen J, Ginman C, Hartvig P, Jakobsson PA, NilssonMi et al: Patient-controlled dose regimen ofmethadone for chronic cancer pain. Br Med J 1981; 282: 771-779 25. Kaiko RF: Age andmorphine analgesia in cancer patients with postoperative pain. Clin Pharamacol Therap 1980;28:823-826 26. Berkowitz BA, Ngai SH, Yang JC, Hempstead J, Spector S. The disposition of morphine in surgical patients. Clin Pharm Therap 1975;17:629-635 27. Owen JA, Sitar DS., Berger L, Brownwell L, Duke PC, Mitensk PA: Age related morphine kinetics. Clin Pharmacol Ther 1983; 34:364368 28. Lipman AG: Drug therapy in terminally ill patients. Am J Hosp Pharm 1975;32:270-276 29. Hansen J, Ginman C, Hartvig P, Jakobsson A, Nilsson MI, Rane Aet al: Clinical evaluation of oral methadone in treatment of cancer pain. Acta Anaesth Scand 1982;(Suppl 74):124-127 30. White PF: use of patient-controlled analgesia for the treatment of acute pain. JAMA 1988;259:242-247 31. Klieman RL, Lipman AG, Hare BD, MacDonald SD: A comparison of morphine administered by patient-controlled analgesia and regularly scheduled intramuscular injection in severe, postoperative pain. J Pain SymptManag 1988;3:15-22 32. Findler G, Olshwang D, Hadani, M: Continuous epidural morphine treatment for intractable pain in terminal cancer patients. Pain 1982;14:311-315 33. Greenberg HS, Taren J, Ensminger WD, Doan K: Benefit from and tolerance to continuous intrathecal infusion of morphine for intractable cancer pain. J. Neurosurgery 1982;57:360-364 34. Leavans ME, Hill CS, Cech DA, Weyland JB, Weston JS: Intrathecal and intraventricular morphine for pain in cancer patients: Initial study. J Neurosurg 1982;56: 241-245 35. Coombs DW, Saunders RL, Gaylor MS, Block AR, Harbaugh R et al: Relief of continuous chronic pain by intraspinal narcotics via an implanted reservoir. JAMA 1983;250, 23362339 36. Porter J, Jick H: Addiction rare in patients treated with narcotics. New Eng J Med (letter) 1980;302:123 37. Twycross RG: Clinical experience with diamorphine in advanced malignant disease. Int J Clin Pharmacol 1974;9:184-198 38.Twycross RG, Lack SA: Symptom control in far advanced cancer: Pain Relief. Pitman, London, England, 1983 39. Walsh TD: Oral morphine in chronic cancer pain. Pain 1984;8:1-11 40. Twycross RG, Fairfield S: Pain in far-advanced cancer. Pain 1982;14:303-310 41. Liebeskind JC, Melzack R: The International Pain Foundation: Meeting a need for education in pain management. Pain (editorial) 1987;30:1-2